Amgen had eight patents in robotics during Q4 2023. Amgen Inc filed a patent for a robotic inspection platform that uses a robotic arm and imager to manipulate containers in different orientations for inspection. The controller analyzes images captured by the imager to determine attributes of the container or sample inside, checking if they meet certain criteria and sorting them accordingly. GlobalData’s report on Amgen gives a 360-degreee view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Amgen Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Amgen grant share with robotics as a theme is 37% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Robotic system for performing pattern recognition-based inspection of pharmaceutical containers (Patent ID: US20230398577A1)

The patent filed by Amgen Inc. describes a robotic inspection platform that utilizes a robotic arm, an imager, and a controller to inspect containers and samples. The robotic arm retrieves and manipulates containers in various orientations while the imager captures images. The controller analyzes these images using pattern recognition to determine attributes of the container or sample, deciding whether they meet specific criteria. If not, the robotic arm places the container in a designated area for rejected items.

The platform's controller can distinguish between different types of objects, such as bubbles and particles, by analyzing images using a pattern recognition model. It can also facilitate training of a machine learning model to classify container and sample attributes by presenting images to a user for manual labeling. The robotic arm's ability to manipulate containers with six degrees of freedom allows for precise orientation adjustments during inspection, ensuring thorough analysis of the container's attributes based on captured images.

To know more about GlobalData’s detailed insights on Amgen, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.